Dr. LaPenna is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
505 E 70th St
New York, NY 10021Phone+1 212-746-2900
Summary
- A New Jersey native currently completing my MD/PhD at the Louisiana State University Health Sciences Center - New Orleans. Graduated from Pennsylvania State University with a double major in Biology and Toxicology . Afterwards, spent two years as a research associate at the Penn State College of Medicine in Hershey, PA before moving down to Louisiana for medical school.
I have spent my graduate school training under the mentorship of David J. Lefer in the Department of Pharmacology and Experimental Therapeutics and Cardiovascular Center of Excellence. My thesis involved studying nitric oxide signaling and protein nitrosylation dynamics in preclincal models of heart failure with preserved ejection fraction (HFpEF).
I look to continue to develop both my clinical and research foundation to progress into an eventual career as an independent physician scientist.
Education & Training
Louisiana State University School of Medicine in New OrleansClass of 2024
Louisiana State University Health Sciences CenterPhD, Pharmacology and Experimental Therapeutics, 2020 - 2022- The Pennsylvania State UniversityB.S., Biology, 2012 - 2016
- The Pennsylvania State UniversityB.S., Toxicology, 2012 - 2016
Publications & Presentations
PubMed
- Adjunctive therapy with an oral HS donor provides additional therapeutic benefit beyond SGLT2 inhibition in cardiometabolic heart failure with preserved ejection fract...Jake E Doiron, Huijing Xia, Xiaoman Yu, Alexandra R Nevins, Kyle B LaPenna
British Journal of Pharmacology. 2024-11-01 - Integrated systems biology identifies disruptions in mitochondrial function and metabolism as key contributors to heart failure with preserved ejection fraction (HFpEF).Andrew A Gibb, Kyle LaPenna, Ryan B Gaspar, Nadina R Latchman, Yinfei Tan
Biorxiv. 2024-10-25 - Impact of progressive chronic kidney disease stage on postoperative outcomes in metabolic surgery-a propensity-matched analysis using the Metabolic and Bariatric Surge...Florina Corpodean, Michael Kachmar, Kyle B LaPenna, Denise Danos, Michael Cook
Surgery for Obesity and Related Diseases. 2024-09-01
External Links
- Researchhttps://scholar.google.com/citations?user=WyXHo18AAAAJ&hl=en&oi=ao
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
